Scrip
Amlodipine generics hit Dainippon Sumitomo
12 May 2009
Ian Haydock
Please Login to read the full article.
12 May 2009
Ian Haydock
ian.haydock@informa.com
Domestic generic competition for top product Amlodin (amlodipine) put pressure on Japan's Dainippon Sumitomo Pharma (DSP) in the year to March 31st.
The July 2008 launch of generics was behind a 9% dip in DSP's sales of the calcium antagonist, which it markets with licensor Pfizer, to ¥57.9...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
